Anti-NF-kB p65 (phospho S529) antibody [EPR2379] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal NF-kB p65 phospho S529 antibody. Carrier free. Suitable for IP, WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
NFKB3, RELA, Transcription factor p65, Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3
- WB
Unknown
Western blot - Anti-NF-kB p65 (phospho S529) antibody [EPR2379] - BSA and Azide free (AB247871)
This data was developed using ab109458, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-NF-kB p65 (phospho S529) antibody [EPR2379] (<a href='/en-us/products/primary-antibodies/nf-kb-p65-phospho-s529-antibody-epr2379-ab109458'>ab109458</a>) at 1/1000 dilution
Lane 1:
Daudi cell lysates untreated with Calyculin A and TNF-alpha. at 10 µg
Lane 2:
Daudi cell lysates treated with Calyculin A and TNF-alpha. at 10 µg
Secondary
All lanes:
HRP-labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 60 kDa
false
Related conjugates and formulations (1)
-
Anti-NF-kB p65 (phospho S529) antibody [EPR2379]
Reactivity data
Product details
ab247871 is the carrier-free version of ab109458.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
NF-kB p65 acts as part of the larger NF-kB complex usually forming a heterodimer with other family members like p50. This complex translocates to the nucleus upon activation where it binds specific DNA sequences to regulate gene expression. The p65 subunit is essential for transactivating target genes involved in immune and inflammatory responses. Its regulation is important for proper cellular functioning especially in the maintenance of immune homeostasis and inflammatory response.
Pathways
NF-kB p65 participates in critical pathways like the NF-kB signaling and Toll-like receptor pathways. These pathways are fundamental for initiating immune responses and contribute to the regulation of apoptosis and cellular stress responses. In the context of these pathways the IKK complex plays a pivotal role in NF-kB activation leading to the phosphorylation and subsequent degradation of inhibitors that retain NF-kB p65 in the cytoplasm therefore allowing its movement to the nucleus.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Immunity, inflammation and disease 10:e692 PubMed36301023
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 13:886226 PubMed35911677
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1259 PubMed34603527
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com